S.Amdt. 532

SA 532. Mr. RUBIO (for himself and Mr. Coons) submitted an amendment
intended to be proposed by him to the bill S. 2226, to authorize
appropriations for fiscal year 2024 for military activities of the
Department of Defense, for military construction, and for defense
activities of the Department of Energy, to prescribe military personnel
strengths for such fiscal year, and for other purposes; which was
ordered to lie on the table; as follows:

At the appropriate place, insert the following:

SEC. __. REVIEW OF DOMESTIC BIOPHARMACEUTICAL MANUFACTURING
CAPABILITIES.

(a) In General.--The Secretary of Health and Human Services
(referred to in this section as the ``Secretary''), in
cooperation with the Director of the Biomedical Advanced
Research and Development Authority, shall seek to enter into
an agreement with the National Institute for Innovation in
Manufacturing Biopharmaceuticals to perform the services
described in subsection (b).
(b) Review and Recommendations.--Under an agreement
described in subsection (a) between the Secretary, the
Director of the Biomedical Advanced Research and Development
Authority, and the National Institute for Innovation in
Manufacturing Biopharmaceuticals, the National Institute for
Innovation in Manufacturing Biopharmaceuticals shall--
(1) review current domestic biopharmaceutical manufacturing
capacity at the Department of Health and Human Services and
such department's adaptability to various threats;
(2) draft recommendations for developing, demonstrating,
deploying, and advancing new domestic biopharmaceutical
manufacturing technologies that address gaps identified under
paragraph (1) and align Federal technologies with
technologies available to the private sector, including
through the new BioMAP initiative of the Biomedical Advanced
Research and Development Authority; and
(3) identify other opportunities and priorities to improve
the United States public health and medical preparedness and
response capabilities and domestic biopharmaceutical
manufacturing capabilities.
______